QuidelOrtho (QDEL) Debt Ratio (2022 - 2026)

QuidelOrtho (QDEL) posted Debt Ratio of 0.48 for Q1 2026, up 3.96% sequentially from 0.46 in Q4 2025, and up 23.44% YoY from 0.39 in Q1 2025.

QuidelOrtho (QDEL) Debt Ratio (2022 - 2026) Analysis & Trends

QuidelOrtho has reported Debt Ratio for 5 years, with the latest figure at 0.48 in Q1 2026.

Quarterly Debt Ratio rose 23.44% year-over-year to 0.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48 (up 23.44% YoY) and the FY2025 annual result came in at 0.46, up 18.83% from the prior year.
Debt Ratio rose to 0.48 in Q1 2026 per QDEL's latest filing, from 0.46 in the prior quarter.
Over five years, Debt Ratio peaked at 0.48 in Q1 2026 and troughed at 0.0 in Q1 2022.
A 5-year average of 0.26 and a median of 0.36 in 2024 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 241253.1% in 2023, down 5.77% in 2023.
Over 5 years, Debt Ratio stood at 0.02 in 2022, then jumped by 1075.65% to 0.28 in 2023, then soared by 37.09% to 0.39 in 2024, then climbed by 18.83% to 0.46 in 2025, then climbed by 3.96% to 0.48 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.48, 0.46, and 0.47 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn	0.30
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn	0.31
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	0.30
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	0.04
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	0.28
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn	0.18
10	QuidelOrtho	1.01 Bn	885.05 Mn	-	0.51

Download Data